Pulse.

a daily field guide to health research that matters

◆ Console

‹ Mon · 9 Nov 2026
Promising but preliminary

CTTN amplification and overexpression predict poor prognosis and immunotherapy resistance in head and neck squamous cell carcinoma.

This study aimed to investigate alterations in CTTN at the DNA, mRNA, and protein levels and evaluate its prognostic significance in overall survival and immunotherapy response in HNSCC. Functional enrichment analysis identified key pathways contributing to HNSCC development and progression.

This study aimed to investigate alterations in CTTN at the DNA, mRNA, and protein levels and evaluate its prognostic significance in overall survival and immunotherapy response in HNSCC. Functional enrichment analysis identified key pathways contributing to HNSCC development and progression.

What the study was

Study design
Cohort study
Category
Treatment Innovation
Maturity
Validated
Journal
Journal of stomatology, oral and maxillofacial surgery

Why it surfaced

⚪ PROMISING_PRELIMINARY — Promising but preliminary; Watchlist: Precision oncology and genomic medicine, Novel therapeutics: immunotherapy, CAR-T, targeted therapy; Design: Cohort study; species: human

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.